Assessing factors influencing communities’ acceptability of mass drug administration for the elimination of lymphatic filariasis in Guyana

BACKGROUND: Guyana is one of four countries in the Latin American Region where lymphatic filariasis (LF) remains endemic. In preparation for the introduction of a new triple drug therapy regimen (ivermectin, diethylcarbamazine, and albendazole (IDA)) in 2019, an acceptability study was embedded with...

Descripción completa

Detalles Bibliográficos
Autores principales: Niles, Reza A., Thickstun, Charles R., Cox, Horace, Dilliott, Daniel, Burgert-Brucker, Clara R., Harding-Esch, Emma M., Clementson, Nikita, Sampson, Annastacia, Alexandre, Jean Seme, Morice Trejos, Ana C., Scholte, Ronaldo G. Carvalho, Krentel, Alison
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8452018/
https://www.ncbi.nlm.nih.gov/pubmed/34543269
http://dx.doi.org/10.1371/journal.pntd.0009596

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8452018/
https://www.ncbi.nlm.nih.gov/pubmed/34543269
http://dx.doi.org/10.1371/journal.pntd.0009596

Ejemplares similares